HOME >> BIOLOGY >> NEWS
The stinky smell of success of Ted the Titan: a tale from Chemical & Engineering News

Ted the Titan stinks like rotting meat, but that's a good thing for Ted, anyway.

Also known as Amorphophallus titanium (or titan arum) and "corpse flower," Ted is a bizarre plant that attracts flies, instead of bees, with its unsavory odor and the insects pollinate it, reports Chemical & Engineering News in its June 30 issue. C&EN is the weekly newsmagazine published by the American Chemical Society, the world's largest scientific society.

Ted is no shrinking violet. It can extend nearly nine feet high. But it produces a bloom only every few years and that bloom stays around only for a day or so. Nearly 1,000 people witnessed the plant's short-lived performance last week at the University of California, Davis, C&EN reports. Originally, the plant was discovered in Sumatra.

"We've had two people gagging already," Ernesto Sandoval, the Davis conservatory's curator cheerfully reported, shortly after the group gathered for the historic event. As the aroma described by some as like rotten eggs laid by a decaying chicken in a clogged drainpipe-wafted through the hall, several other people began gagging, according to C&EN.

The precise chemistry of Ted's odor hasn't really been explained as yet, but some scientists have some strong suspicions. UC Davis plant biology professor Terence M. Murphy says tests on other related plants reveal compounds that have a characteristic rotting meat smell, such as dimethyl trisulfide. And they also have detected amines in related plants with such names as putrescine and cadaverine, which also are produced by rotting meat.

UC Davis entomology professor Bruce D. Hammock says he hopes to solve the mystery soon. He says he realized no one was doing chemical analyses of the plant so he and some colleagues are running a series of tests, the newsmagazine says. They're still waiting for the results, but as Hammock puts it: "my nose as a chemist tells me [the compou
'"/>

Contact: Michael Bernstein
m_bernstein@acs.org
202-872-6042
American Chemical Society
30-Jun-2003


Page: 1 2

Related biology news :

1. Essential smell gene may provide key to new insect repellents
2. Virginia Techs smelly corpse plant due to bloom Aug. 4
3. AChemS: Cutting edge research in taste, smell, & chemical irritation
4. Rockefeller University scientists take on controversial vibration theory of smell
5. Primates trade smell for sight
6. Progress in probing the mosquitos sense of smell
7. Ability to smell food regulated by enzymes interaction with RNA interference pathway
8. Stop to smell the flowers - But do it before theyre pollinated
9. Alcohols pharmacological properties, not smell or taste, reinforce its effects
10. Weizmann Institute scientists report why taste and smell differ among individuals
11. Human sperm may smell their way to the egg, Science study suggests

Post Your Comments:
(Date:10/18/2014)... suspected genetic conditions, a certain type of exome sequencing ... than traditional molecular diagnostic methods, according to a study ... released to coincide with the American Society of Human ... protein­coding region of the genome (the complete set of ... organism), has been rapidly applied in research settings and ...
(Date:10/17/2014)... release is available in German . ... of sperms every day in order to reproduce? And why ... the topic of the latest issue of the research journal ... The evolutionary biologist Steven Ramm from Bielefeld University Bielefeld has ... is not unusual for a female to copulate with several ...
(Date:10/17/2014)... To date, antidotes ... doctors are often limited to supportive therapy such as induced ... of drugs involved. So what can be done if a ... professor Jean-Christophe Leroux from the Institute of Pharmaceutical Sciences at ... "The task was to develop an agent that could eliminate ...
Breaking Biology News(10 mins):Study examines type of exome sequencing and molecular diagnostic yield 2Study examines type of exome sequencing and molecular diagnostic yield 3Sperm wars 2Emergency aid for overdoses 2Emergency aid for overdoses 3
(Date:10/22/2014)... Oct. 22, 2014   Synthetic Biologics, Inc. ... therapies for serious infections and diseases, announced today that ... Notice of Allowance for a composition of matter patent ... difficile program, SYN-004. This is Synthetic Biologics, first ... U.S. and adds to the Company,s extensive C. ...
(Date:10/22/2014)... and HONG KONG , Oct. ... disease therapeutics enterprise, announced today that rare disease expert ... as vice president, research. Dr. McKew brings more than ... leadership positions at the National Institutes of Health, Wyeth ... by Wyeth). Dr. McKew will lead aTyr,s efforts to expand ...
(Date:10/20/2014)... 20, 2014 Asterias Biotherapeutics, Inc. (NYSE ... signed a Notice of Grant Award (NGA) with ... October 1, 2014.  The NGA provides for the ... release of additional grant funds pursuant to the ... clinical development of Asterias, product, AST-OPC1. The grant ...
(Date:10/20/2014)... BOSTON , Oct. 20, 2014 ... commercialization company tackling big healthcare problems, announced today ... investment round, with participation from Invesco Perpetual, a ... be used to drive PureTech,s existing pipeline forward ... technologies. "PureTech has the scientific creativity to really ...
Breaking Biology Technology:Synthetic Biologics Announces Allowance of Key U.S. Composition of Matter Patent for C. difficile Program 2Synthetic Biologics Announces Allowance of Key U.S. Composition of Matter Patent for C. difficile Program 3Synthetic Biologics Announces Allowance of Key U.S. Composition of Matter Patent for C. difficile Program 4aTyr Pharma Appoints John C. McKew, Ph.D., as Vice President, Research 2aTyr Pharma Appoints John C. McKew, Ph.D., as Vice President, Research 3Asterias Biotherapeutics Announces Notice of Grant Award with CIRM for Phase 1/2a Clinical Trial of AST-OPC1 in Complete Cervical Spinal Cord Injury 2Asterias Biotherapeutics Announces Notice of Grant Award with CIRM for Phase 1/2a Clinical Trial of AST-OPC1 in Complete Cervical Spinal Cord Injury 3Asterias Biotherapeutics Announces Notice of Grant Award with CIRM for Phase 1/2a Clinical Trial of AST-OPC1 in Complete Cervical Spinal Cord Injury 4PureTech Announces Expansion with Oversubscribed $55M Funding Round 2PureTech Announces Expansion with Oversubscribed $55M Funding Round 3PureTech Announces Expansion with Oversubscribed $55M Funding Round 4PureTech Announces Expansion with Oversubscribed $55M Funding Round 5PureTech Announces Expansion with Oversubscribed $55M Funding Round 6
Cached News: